Enanta Pharmaceuticals Inc
ENTA
|
|
| |
|
| Trading Volume | 3,038 |
|
|
17.42 - 8.18 |
| Market Cap Full | $ 273.8M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -3% | 85.1% | -13.1% | -4.8% |
| Q2 | - | -25.6% | -47.1% | -33.6% |
| Q3 | - | -11.9% | -47.8% | 9.7% |
| Q4 | - | -48.2% | -10.3% | -10.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 29.1 | 18.3 | 21.2 | -23.8 | -6 | 1.4 | 16.5 | -11.9 | - | - | - | -33.4 |
| 2023 | |||||||||||
| 14.8 | -9.1 | -16.6 | -12.1 | -34 | -8.9 | -11.4 | -21.7 | -24.8 | -19.3 | 3.6 | 0.8 |
| 2022 | |||||||||||
| -20.5 | 18.5 | 1.1 | -9.5 | -37.9 | 18.3 | 16.7 | 10.4 | -14.8 | -13 | -2.9 | 6.2 |
| 2021 | |||||||||||
| 14.2 | 3.1 | -0.4 | 2.9 | -4.1 | -9.6 | -4.3 | 35.8 | -0.7 | 47.9 | 5.1 | -15.3 |
| 2020 | |||||||||||
| -17.3 | -0.8 | 1.1 | -9.8 | 11 | -2.5 | -8.7 | 13.8 | -12.3 | -4.7 | -4.2 | 0.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -1.8 | -1.6 | -1.1 | -0.3 |
| Q2 | -1.9 | -1.5 | -1.2 | -0.7 |
| Q3 | -1.3 | -1.3 | -1.2 | -1.5 |
| Q4 | 0 | -1.4 | -1.5 | -0.4 |
| A | -4.99 | -5.9 | -3.9 | -1.8 |